Sysmex Corporation Logo

Sysmex Corporation

SSMXY

(2.2)
Stock Price

20,07 USD

10.02% ROA

12.21% ROE

34.93x PER

Market Cap.

1.818.001.921.997,80 USD

12.97% DER

0% Yield

10.89% NPM

Sysmex Corporation Stock Analysis

Sysmex Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Sysmex Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

2 DER

The stock has a low debt to equity ratio (7%), which means it has a small amount of debt compared to the ownership it holds

3 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

4 ROE

The stock's ROE falls within an average range (12.34%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

5 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

6 Buffet Intrinsic Value

The company's stock seems undervalued (35.317) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

7 PBV

The stock's elevated P/BV ratio (4.57x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

8 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

10 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

11 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

Sysmex Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Sysmex Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Sysmex Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Sysmex Corporation Revenue
Year Revenue Growth
2004 76.934.000.000
2005 87.887.000.000 12.46%
2006 101.041.000.000 13.02%
2007 110.724.000.000 8.75%
2008 111.842.000.000 1%
2009 116.174.000.000 3.73%
2010 124.694.000.000 6.83%
2011 134.743.000.000 7.46%
2013 145.577.000.000 7.44%
2014 184.538.000.000 21.11%
2015 221.376.000.000 16.64%
2016 252.622.000.000 12.37%
2017 249.899.000.000 -1.09%
2018 281.935.000.000 11.36%
2019 293.506.000.000 3.94%
2020 301.980.000.000 2.81%
2021 305.073.000.000 1.01%
2022 363.780.000.000 16.14%
2023 469.388.000.000 22.5%
2023 410.502.000.000 -14.34%
2024 461.510.000.000 11.05%
2025 447.784.000.000 -3.07%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Sysmex Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2013 12.119.000.000 100%
2014 13.260.000.000 8.6%
2015 14.692.000.000 9.75%
2016 15.409.000.000 4.65%
2017 15.554.000.000 0.93%
2018 16.754.000.000 7.16%
2019 19.578.000.000 14.42%
2020 21.761.000.000 10.03%
2021 22.517.000.000 3.36%
2022 26.784.000.000 15.93%
2023 31.520.000.000 15.03%
2023 31.060.000.000 -1.48%
2024 31.402.000.000 1.09%
2025 29.424.000.000 -6.72%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Sysmex Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 83.545.000.000 100%
2021 82.621.000.000 -1.12%
2022 94.235.000.000 12.32%
2023 129.772.000.000 27.38%
2023 112.371.000.000 -15.49%
2024 133.798.000.000 16.01%
2025 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Sysmex Corporation EBITDA
Year EBITDA Growth
2004 13.208.000.000
2005 15.603.000.000 15.35%
2006 17.592.000.000 11.31%
2007 19.015.000.000 7.48%
2008 21.102.000.000 9.89%
2009 23.619.000.000 10.66%
2010 25.625.000.000 7.83%
2011 27.247.000.000 5.95%
2013 30.616.000.000 11%
2014 44.267.000.000 30.84%
2015 57.365.000.000 22.83%
2016 72.820.000.000 21.22%
2017 63.203.000.000 -15.22%
2018 74.590.000.000 15.27%
2019 76.641.000.000 2.68%
2020 78.456.000.000 2.31%
2021 74.581.000.000 -5.2%
2022 96.997.000.000 23.11%
2023 117.616.000.000 17.53%
2023 104.459.000.000 -12.6%
2024 113.185.000.000 7.71%
2025 106.124.000.000 -6.65%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Sysmex Corporation Gross Profit
Year Gross Profit Growth
2004 44.131.000.000
2005 51.148.000.000 13.72%
2006 57.544.000.000 11.11%
2007 65.328.000.000 11.92%
2008 71.004.000.000 7.99%
2009 73.694.000.000 3.65%
2010 78.305.000.000 5.89%
2011 83.091.000.000 5.76%
2013 88.995.000.000 6.63%
2014 115.724.000.000 23.1%
2015 126.018.000.000 8.17%
2016 150.690.000.000 16.37%
2017 141.777.000.000 -6.29%
2018 158.949.000.000 10.8%
2019 161.607.000.000 1.64%
2020 159.807.000.000 -1.13%
2021 154.303.000.000 -3.57%
2022 190.585.000.000 19.04%
2023 242.424.000.000 21.38%
2023 216.083.000.000 -12.19%
2024 242.497.000.000 10.89%
2025 240.160.000.000 -0.97%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Sysmex Corporation Net Profit
Year Net Profit Growth
2004 5.731.000.000
2005 7.422.000.000 22.78%
2006 9.008.000.000 17.61%
2007 9.131.000.000 1.35%
2008 8.013.000.000 -13.95%
2009 9.764.000.000 17.93%
2010 11.411.000.000 14.43%
2011 12.007.000.000 4.96%
2013 14.165.000.000 15.23%
2014 20.573.000.000 31.15%
2015 26.638.000.000 22.77%
2016 39.278.000.000 32.18%
2017 40.635.000.000 3.34%
2018 39.221.000.000 -3.61%
2019 41.224.000.000 4.86%
2020 34.882.000.000 -18.18%
2021 31.904.000.000 -9.33%
2022 44.092.000.000 27.64%
2023 54.260.000.000 18.74%
2023 45.784.000.000 -18.51%
2024 49.639.000.000 7.77%
2025 44.124.000.000 -12.5%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Sysmex Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 28
2005 18 -55.56%
2006 22 18.18%
2007 22 0%
2008 20 -15.79%
2009 48 59.57%
2010 28 -74.07%
2011 15 -92.86%
2013 23 36.36%
2014 33 33.33%
2015 43 21.43%
2016 63 33.33%
2017 65 3.08%
2018 63 -4.84%
2019 66 4.62%
2020 56 -18.18%
2021 51 -10%
2022 70 28.57%
2023 130 45.74%
2023 73 -79.17%
2024 79 8.86%
2025 71 -12.86%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Sysmex Corporation Free Cashflow
Year Free Cashflow Growth
2004 2.545.000.000
2005 1.059.000.000 -140.32%
2006 3.970.000.000 73.32%
2007 909.000.000 -336.74%
2008 2.219.000.000 59.04%
2009 14.805.000.000 85.01%
2010 10.345.000.000 -43.11%
2011 8.619.000.000 -20.03%
2013 16.198.000.000 46.79%
2014 23.281.000.000 30.42%
2015 25.607.000.000 9.08%
2016 19.710.000.000 -29.92%
2017 13.726.000.000 -43.6%
2018 26.545.000.000 48.29%
2019 15.765.000.000 -68.38%
2020 26.710.000.000 40.98%
2021 28.970.000.000 7.8%
2022 24.809.000.000 -16.77%
2023 7.191.000.000 -245%
2023 25.684.000.000 72%
2024 12.873.000.000 -99.52%
2025 13.223.000.000 2.65%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Sysmex Corporation Operating Cashflow
Year Operating Cashflow Growth
2004 6.691.000.000
2005 8.275.000.000 19.14%
2006 10.085.000.000 17.95%
2007 11.634.000.000 13.31%
2008 13.193.000.000 11.82%
2009 21.229.000.000 37.85%
2010 18.135.000.000 -17.06%
2011 17.058.000.000 -6.31%
2013 25.806.000.000 33.9%
2014 36.563.000.000 29.42%
2015 38.640.000.000 5.38%
2016 41.794.000.000 7.55%
2017 32.832.000.000 -27.3%
2018 52.240.000.000 37.15%
2019 44.743.000.000 -16.76%
2020 53.182.000.000 15.87%
2021 56.873.000.000 6.49%
2022 58.739.000.000 3.18%
2023 19.328.000.000 -203.91%
2023 68.835.000.000 71.92%
2024 63.905.000.000 -7.71%
2025 17.966.000.000 -255.7%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Sysmex Corporation Capital Expenditure
Year Capital Expenditure Growth
2004 4.146.000.000
2005 7.216.000.000 42.54%
2006 6.115.000.000 -18%
2007 10.725.000.000 42.98%
2008 10.974.000.000 2.27%
2009 6.424.000.000 -70.83%
2010 7.790.000.000 17.54%
2011 8.439.000.000 7.69%
2013 9.608.000.000 12.17%
2014 13.282.000.000 27.66%
2015 13.033.000.000 -1.91%
2016 22.084.000.000 40.98%
2017 19.106.000.000 -15.59%
2018 25.695.000.000 25.64%
2019 28.978.000.000 11.33%
2020 26.472.000.000 -9.47%
2021 27.903.000.000 5.13%
2022 33.930.000.000 17.76%
2023 12.137.000.000 -179.56%
2023 43.151.000.000 71.87%
2024 51.032.000.000 15.44%
2025 4.743.000.000 -975.94%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Sysmex Corporation Equity
Year Equity Growth
2004 55.347.000.000
2005 61.786.000.000 10.42%
2006 71.345.000.000 13.4%
2007 78.990.000.000 9.68%
2008 79.761.000.000 0.97%
2009 87.024.000.000 8.35%
2010 94.134.000.000 7.55%
2011 102.380.000.000 8.05%
2013 119.152.000.000 14.08%
2014 146.249.000.000 18.53%
2015 169.550.000.000 13.74%
2016 182.801.000.000 7.25%
2017 210.252.000.000 13.06%
2018 241.443.000.000 12.92%
2019 265.182.000.000 8.95%
2020 278.347.000.000 4.73%
2021 306.089.000.000 9.06%
2022 349.053.000.000 12.31%
2023 388.356.000.000 10.12%
2023 420.122.000.000 7.56%
2024 432.897.000.000 2.95%
2025 448.783.000.000 3.54%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Sysmex Corporation Assets
Year Assets Growth
2004 77.660.000.000
2005 87.446.000.000 11.19%
2006 101.225.000.000 13.61%
2007 109.027.000.000 7.16%
2008 118.521.000.000 8.01%
2009 120.702.000.000 1.81%
2010 130.059.000.000 7.19%
2011 142.285.000.000 8.59%
2013 173.010.000.000 17.76%
2014 210.758.000.000 17.91%
2015 247.983.000.000 15.01%
2016 263.917.000.000 6.04%
2017 279.817.000.000 5.68%
2018 321.979.000.000 13.09%
2019 346.775.000.000 7.15%
2020 389.291.000.000 10.92%
2021 424.895.000.000 8.38%
2022 483.707.000.000 12.16%
2023 531.074.000.000 8.92%
2023 557.834.000.000 4.8%
2024 618.920.000.000 9.87%
2025 626.249.000.000 1.17%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Sysmex Corporation Liabilities
Year Liabilities Growth
2004 21.511.000.000
2005 24.800.000.000 13.26%
2006 28.829.000.000 13.98%
2007 29.910.000.000 3.61%
2008 38.671.000.000 22.66%
2009 33.566.000.000 -15.21%
2010 35.827.000.000 6.31%
2011 39.783.000.000 9.94%
2013 53.858.000.000 26.13%
2014 64.509.000.000 16.51%
2015 78.433.000.000 17.75%
2016 82.864.000.000 5.35%
2017 71.248.000.000 -16.3%
2018 80.531.000.000 11.53%
2019 81.588.000.000 1.3%
2020 110.941.000.000 26.46%
2021 118.955.000.000 6.74%
2022 134.898.000.000 11.82%
2023 142.715.000.000 5.48%
2023 137.712.000.000 -3.63%
2024 186.020.000.000 25.97%
2025 177.466.000.000 -4.82%

Sysmex Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
766.72
Net Income per Share
83.47
Price to Earning Ratio
34.93x
Price To Sales Ratio
3.8x
POCF Ratio
25.78
PFCF Ratio
72.9
Price to Book Ratio
4.06
EV to Sales
3.74
EV Over EBITDA
15.14
EV to Operating CashFlow
25.38
EV to FreeCashFlow
71.78
Earnings Yield
0.03
FreeCashFlow Yield
0.01
Market Cap
1.818,00 Bil.
Enterprise Value
1.790,03 Bil.
Graham Number
1161.54
Graham NetNet
87.34

Income Statement Metrics

Net Income per Share
83.47
Income Quality
1.36
ROE
0.12
Return On Assets
0.08
Return On Capital Employed
0.16
Net Income per EBT
0.65
EBT Per Ebit
0.99
Ebit per Revenue
0.17
Effective Tax Rate
0.33

Margins

Sales, General, & Administrative to Revenue
0.22
Research & Developement to Revenue
0.07
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.53
Operating Profit Margin
0.17
Pretax Profit Margin
0.17
Net Profit Margin
0.11

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0.34
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
113.1
Free CashFlow per Share
39.99
Capex to Operating CashFlow
0.65
Capex to Revenue
0.1
Capex to Depreciation
1.22
Return on Invested Capital
0.11
Return on Tangible Assets
0.1
Days Sales Outstanding
111.92
Days Payables Outstanding
44.62
Days of Inventory on Hand
142.68
Receivables Turnover
3.26
Payables Turnover
8.18
Inventory Turnover
2.56
Capex per Share
73.11

Balance Sheet

Cash per Share
124,78
Book Value per Share
719,70
Tangible Book Value per Share
548.11
Shareholders Equity per Share
718.41
Interest Debt per Share
97.33
Debt to Equity
0.13
Debt to Assets
0.09
Net Debt to EBITDA
-0.24
Current Ratio
3.23
Tangible Asset Value
341,79 Bil.
Net Current Asset Value
164,85 Bil.
Invested Capital
462101000000
Working Capital
236,47 Bil.
Intangibles to Total Assets
0.17
Average Receivables
160,57 Bil.
Average Payables
24,87 Bil.
Average Inventory
83729000000
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Sysmex Corporation Dividends
Year Dividends Growth
2012 0
2013 0 0%
2014 1 0%
2015 0 0%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 0%
2020 1 0%
2021 1 0%
2022 1 0%
2023 1 0%

Sysmex Corporation Profile

About Sysmex Corporation

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. Sysmex Corporation has a strategic alliance with QIAGEN N.V. for the development and commercialization of cancer companion diagnostics using Plasma-Safe-SeqS technology. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

CEO
Mr. Kaoru Asano
Employee
10.042
Address
1-5-1, Wakinohama-Kaigandori
Kobe, 651-0073

Sysmex Corporation Executives & BODs

Sysmex Corporation Executives & BODs
# Name Age
1 Mr. Frank Buescher
Senior Executive Officer
70
2 Mr. Kenji Tachibana
Senior Managing Executive Officer & Director
70
3 Mr. Tomokazu Yoshida
Managing Executive Officer, Chief Technology Officer & Director
70
4 Mr. Kensuke Iizuka
Senior Executive Officer & Executive Vice President of Corporate Business Planning Div.
70
5 Mr. Zuo Hui Peng
Executive Officer
70
6 Mr. Takashi Ono
Director & Senior Executive Officer
70
7 Mr. Mitsuhisa Kanagawa
Senior Exec Officer of IVD Business Unit & EVice President of Business Strategy Dev
70
8 Mr. Kaoru Asano
President & Representative Director
70
9 Mr. Iwane Matsui
Senior Managing Executive Officer & Director
70
10 Mr. Chris Cappella
Chief Financial Officer
70

Sysmex Corporation Competitors